| Literature DB >> 22363833 |
Bojana Kisic1, Dijana Miric, Lepsa Zoric, Aleksandra Ilic, Ilija Dragojevic.
Abstract
The immediate cause of the occurrence of cataract is unknown, but oxidative damage and effects of reactive oxygen species are considered important in its etiopathogenesis. Our research was aimed at testing the nonenzyme antioxidant power of corticonuclear lens blocks, with different types and different maturity of age-related cataract. Clinical and biochemical researches were carried out in 101 patients with age-related cataract. In corticonuclear lens blocks of the patient, the concentration of nonprotein and total-SH groups and the concentration of total vitamin C and dehydroascorbic acid (DHA) were determined; the current redox balance of dehydroascorbate/ascorbate and total antioxidant power measured by ferric-reducing ability were examined. In corticonuclear lens blocks with incipient cataract a significantly higher concentration of GSH, total SH groups, concentration of total vitamin C and ascorbic acid (AA), and ferric-reducing ability were measured. The measured concentration of DHA is higher than the concentration of AA in the lenses with the incipient and mature cataract. The concentration ratio of redox couple DHA/AA is higher in lenses with mature cataract, where the measured concentration of AA was lower than in the incipient cataract. Timely removal of DHA from the lens is important because of its potential toxicity as an oxidant. An increase of the current concentration of DHA/AA redox balance can be an indicator of oxidative stress.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22363833 PMCID: PMC3272861 DOI: 10.1155/2012/467130
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Nonenzymatic antioxidative defense factors in cataractous lenses.
| Age-related cataract incipiens ( | Age-related cataract matura ( | |
|---|---|---|
| GSH( | 2.6 ± 0.9 | 0.9 ± 0.3* |
| TSH( | 102.5 ± 25.5 | 54.8 ± 19.7* |
| Total vitamin C ( | 0.61 ± 0.19 | 0.46 ± 0.16* |
| AA ( | 0.19 ± 0.07 | 0.11 ± 0.04* |
| DHA ( | 0.41 ± 0.13 | 0.38 ± 0.13 |
| D/A | 2.3 ± 0.6 | 3.4 ± 0.7* |
| FRAL( | 4.0 ± 1.3 | 1.4 ± 0.4* |
Data is presented as means ± SD *P < 0.001. GSH—Glutathione reduced TSH—Total-SH group AA—Ascorbic acid DHA—dehydroascorbic acid D/A—Dehydroascorbic acid/ascorbic acid FRAL—Ferric-reducing ability of lens.
Figure 1Lens total vitamin C and FRAL relationship in age-related cataract.
Figure 2Lens ascorbic acid and FRAL relationship in age-related cataract.
Figure 3Lens GSH and FRAL relationship in age-related cataract.
Figure 4Lens T-SH and FRAL relationship in age-related cataract.
Multiple regression analysis.
| Variable | SE | ||
|---|---|---|---|
| FRAL ( | 0.153 | ||
| GSH ( | 0.103 | 0.484 | <0.001* |
| TSH ( | 3.123 | 0.107 | 0.156 |
| AA ( | 0.007 | 0.358 | 0.008* |
| DHA ( | 0.014 | 0.11 | 0.272 |
| D/A | 0.091 | −0.051 | 0.617 |
Figure 5Lens GSH and total vitamin C relationship in age-related cataract.
Figure 6Lens GSH and ascorbic acid relationship in age-related cataract.
Nonenzymatic antioxidative defense factors in lenses with cataract incipiens.
| Cataract incipiens (type) | PS | NP | CN |
|---|---|---|---|
| GSH ( | 3.0 ± 0.9 | 2.2 ± 0.6* | 1.8 ± 0.4** |
| TSH ( | 114.2 ± 26.3 | 89.2 ± 18.6* | 85.8 ± 10.8** |
| Total vitamin C ( | 0.64 ± 0.2 | 0.52 ± 0.17 | 0.61 ± 0.15 |
| AA ( | 0.2 ± 0.08 | 0.16 ± 0.06 | 0.09 ± 0.19 |
| DHA ( | 0.44 ± 0.14 | 0.36 ± 0.13 | 0.41 ± 0.11 |
| D/A | 2.3 ± 0.7 | 2.3 ± 0.6 | 2.2 ± 0.6 |
| FRAL ( | 4.5 ± 1.2 | 3.6 ± 1.2 | 3.4 ± 0.5* |
Data is presented as means ± SD, *P < 0.05, **P < 0.01. PS—Posterior subcapsular NP—Nuclear subcapsular CN—Cortical nuclear.
Nonenzymatic antioxidative defense factors in lenses with cataract matura.
| Cataract matura (type) | Age-related cataract matura began as PS ( | Age-related cataract matura began as NP ( | Age-related cataract matura began as CN ( |
|---|---|---|---|
| GSH ( | 1.0 ± 0.2 | 0.8 ± 0.2 | 0.8 ± 0.3 |
| TSH ( | 59.9 ± 16.6 | 58.0 ± 20.8 | 48.2 ± 21.9 |
| Total vitamin C ( | 0.49 ± 0.18 | 0.43 ± 0.19 | 0.44 ± 0.07 |
| AA ( | 0.12 ± 0.05 | 0.1 ± 0.04 | 0.1 ± 0.02 |
| DHA ( | 0.37 ± 0.14 | 0.33 ± 0.15 | 0.44 ± 0.07* |
| D/A | 3.4 ± 0.8 | 3.4 ± 0.7 | 3.5 ± 0.6 |
| FRAL ( | 1.6 ± 0.5 | 1.4 ± 0.5 | 1.2 ± 0.2* |
Data is presented as means ± SD, *P < 0.05. PS—posterior subcapsular NP—nuclear subcapsular CN—cortical nuclear.